MP IDMA & AIPAC to organise one-day symposium on ‘Dissolution Science and Technology’ in Indore on December 12: Our Bureau, Chennai Wednesday, December 4, 2024, 16:15 Hrs [IST ...
Senti Biosciences announces oversubscribed $37.6 million private placement equity financing: South San Francisco, California Wednesday, December 4, 2024, 14:30 Hrs [IST] Senti Bio ...
Genethon & Hansa begin phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome: Lund, Sweden Wednesday, December 4, 2024, 18:00 Hrs [IST] Hans ...
Dentalkart gets Rs. 85 crore funding from FIIs to accelerate growth and expand subsidiaries: Our Bureau, Bengaluru Wednesday, December 4, 2024, 17:30 Hrs [IST] Dentalkart, Indias ...
Karnataka govt appoints BP Arun as new licensing, controlling and approving authority to the state drugs control department: Our Bureau, Bengaluru Wednesday, December 4, 2024, 15: ...
Medexus, medac conclude negotiations to amend treosulfan agreement in US, setting regulatory milestone amounts and payment schedule: Toronto, Ontario Wednesday, December 4, 2024, ...
Thryve Digital Health honoured with dual win at the Indian CSR Awards 2024: Our Bureau, Mumbai Wednesday, December 4, 2024, 17:15 Hrs [IST] Thryve Digital Health, a leading provid ...
Ainos inks MoU with Taiwan Tanabe Seiyaku to advance manufacturing and Taiwan market promotion of Sjögren's syndrome drug, Veldona: San Diego, California Wednesday, December 4, 2 ...
Nyctea Technologies brings electrified purification to drug development to accelerate medical innovation: Gothenburg, Sweden Wednesday, December 4, 2024, 17:00 Hrs [IST] Swedish d ...
The UK Government has agreed a contract for more than five million doses of human H5 influenza vaccine to boost the country’s resilience in the event of a possible H5 influenza pandemic. The vaccine, ...
MediBuddy launches India Health Care Collaborators to enable insurance-integrated healthcare: Our Bureau, Bengaluru Wednesday, December 4, 2024, 13:45 Hrs [IST] MediBuddy has laun ...
US FDA grants orphan drug designation to AlveoGene’s novel, inhaled gene therapy, AVG-002 for lethal neonatal surfactant protein B deficiency: Oxford, UK Wednesday, December 4, ...